| Recruitment status | Recruiting |
| Unique ID issued by UMIN | UMIN000021576 |
| Receipt No. | R000024818 |
| Official scientific title of the study | Effects of perioperative enteral nutrition. |
| Date of disclosure of the study information | 2016/03/31 |
| Last modified on | 2016/05/29 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Effects of perioperative enteral nutrition. | |
| Title of the study (Brief title) | Effects of perioperative enteral nutrition. | |
| Region |
|
|
| Condition | ||
| Condition | perioperative states. | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the effects of perioperative enteral nutrition. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | blood suger, keton body. |
| Key secondary outcomes | Lactate, pH and base excess of blood gas analysis, gastric pH, gastric fluid volume, concentration of insulin, mean blood pressures, heart rates, urine volume. |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 2 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Use acetate ringer with 1% glucose. | ||
| Interventions/Control_2 | Use acetate ringer with 1% glucose and OS-1. | ||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Elective non-abdominal operation over three hours. | |||
| Key exclusion criteria | 1. Patients with past history of gastrointestinal surgery.
2. patients undergoing high calorie infusion therapy. 3. patients with diabetes melitus or other endocrine dysfunctions. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Kishiko Nakai |
| Organization | Hirosaki university hospital |
| Division name | Anesthesiology |
| Address | Zaihuchou 5, Hirosaki city |
| TEL | 0172-39-5113 |
| kishiko_sk1064@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Erika Amanai |
| Organization | Hirosaki university hospital |
| Division name | Anesthesiology |
| Address | Zaihuchou 5, Hirosaki ctiy |
| TEL | 0172-39-5113 |
| Homepage URL | |
| e.amanai@gmail.com | |
| Sponsor | |
| Institute | Department of Anesthesiology, Hirosaki university hospital |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Department of Anesthesiology, Hirosaki university hospital |
| Organization | |
| Division | |
| Category of Funding Organization | |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000024818 |